Clinical Trial Update: Evaluation of the Effects of the Product RV5075A-MF6793 in Diabetic Patients Presenting Foot Xerosis and Superficial Fissures, an Exploratory Study. [NA]

View source ↗

Summary

Completed exploratory clinical trial evaluating RV5075A-MF6793 in diabetic patients with foot xerosis and superficial fissures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Disease
• Xerosis Cutis

Drugs mentioned

• RV5075A-MF6793

Snippet

Sponsor: Pierre Fabre Dermo Cosmetique | Conditions: Diabetic Foot Xerosis | NA | Status: COMPLETED